OUR TECHNOLOGY
Directly addressing the inherent limitations of current CRISPR methodologies, our technology seeks to unlock previously unattainable avenues in the development of CRISPR based therapeutics.
TECHNOLOGICAL FEATURES
Unprecedented
Homology-Directed
Repair Rates
Accounts for
Immunogenicity
Unique
RNP Delivery
Validated
CRISPR Nuclease
"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
PROF. GEORGE CHURCH, CRISPR PIONEER
FIND OUT MORE.I
CONTACT US.
AddressIn
Institut NEOMED
7171 Frederick Banting
Saint-Laurent H4S 1Z9
(Québec) Canada